Professional Documents
Culture Documents
/
2557
KPI
Template
2557
( KPI
)
HA
.
KPI Template CUP 2557
(..)
......
......
......
()
10 2557
...
TH SarabunPSK
16
..
3 ./-- 2 .
KPI Template
1
12
/
60
1 ( /
)
12
100
12 x 100
/ /
(
)
:
1
40
2
45
3
50
4
55
5
60
25 25 25 25 25 25
51 52 53 54 55 56
43. 44 43 52 54 58.
7
.5 .6 .8 .2 3
12
2
5
/
60
5
100
5 x 100
/ /
(
)
:
1
40
2
45
3
50
4
55
5
60
25 25 25 25 25 25
51 42 53 54 55 56
NA NA NA NA 52 53.
.8 6
3 :
/ : 31
(
2557)
Major Depressive Disorder
x 100
/ /
:
-
-
:
1
10
2
15
3
20
4
25
5
30
2553 2554 2555 2556
20.4
23.1
28.4
37.2
1.
(Major Psychosis F20-25, F28F29) (CUP)
HN
2. (Major Psychosis F20-25,
F28-F29)
(CUP)
HN
(Major
Psychosis F20-25, F28-F29)
(F20-25, F28-F29) +
CUP x 100
CUP
/ /
-
-
:
10
1
40
2
50
3
60
4
70
5
80
(Major
2553 2554 2555 2556
NA
NA
60.4
77.5
3
/ :
50
: 1
:
3 2556
57.89
3.2 9
1-3
11
3 2
11 29
100
4 5
30
35
40
45
50
50%
//
( 01)
12
3 ( 4 )
2
1 3
52
62.3
2
53
60.2
7
54
60.8
2
55
58.1
8
56
57.8
9
20.6
5
31.8
5
32.1
1
34.6
8
: 0
: 2
: .6
(,
13
: 12 (.6)
12 (.6) () x 100
()
:
1
/
45
50
55
60
12
40
(.6)
/ :
.6 20%
.6 CUP ..-..
CUP
:
: 089 - 7084728
: 086 9276668
14
7 :
/ : 30 1
:
: 1. 60
(UC , ,
) 13
16 16
2. 50 - 59 (UC
, ,
) 13
16
:
()
()
:
1
/
15
22
24
26
28
30
/ :
: 089 - 7084728
:
: 087 1958717
16
/
/
: 1.5
X 100
//
17
1
2
3
4
5
3
25
30
35
40
45
.
(Baseline Data)
2554 2555 2556
6.05 7.28 7.74
2554 2555 2556
6.05
7.28
7.74
18
51.19
48.03
48.39
35.22
39.12
36.94
39.86
39.30
41.79
41.54
38.95
40.11
35.00
32.32
37.83
39.94
37.12
37.51
28.58
40.04
42.26
27.21
26.61
26.17
10
37.00
37.80
36.71
11
43.79
45.09
44.99
12
52.11
39.44
41.19
13
37.01
40.22
34.49
(.)
19
/ : 1.
100
2.
90
1.
1
2.
0.5
1.
2.
2.1
GMP
.1(50) /
2.2
.3(50)
20
2.3
.5(50)
/
2.4
General GMP 57 . 9(55)
/
2.5
2.6
2.7
GMP
3.
3.1
GMP GMP
60
21
3.2
GMP 70
3.3
60
3.4
(major defect)
1.
CUP
x 100
2.
x 100
//
22
1
2
3
4
5
60
70
80
90
100
50
60
70
80
90
1.
CUP (
CUP ) (
CUP )
2.
2556
()
/
255 255 255 255 255
2
3
4
5
6
90
90
95
90.5 92.2
23
General GMP
85.5
10
.
/ : 75
:
1.5
:
1.
1.1
1.2
2. .
. .
24
7 56 15
105
2.1
50
2.2
50
75
2.3
75
90
2.4
90
3. .
75
cup
10
12
4. .
25
1. .
.
2.
.
1
30 2557
3.
.
.
20
3
(SI-2) 3
3
4.
26
1.
.
2.
3. .
- ,
2
1 30 2557
2 31 2557
5.
6.
:
x 100
27
//
:
1, .
2.
2.1
2.2
2.3 .
10
30
50
70
75
:
.
2556
58
30
13
363
464
28
31
22
19
60
132
14
33
94
57
41
43
7
629
: 081-8873562
1. .
: 083-2178557
2. .
0 5623 2001 6 140,141
29
11
5
1.5
:
1.
5
1
.. 2556
.. 2557
2 /
.
30
3
4
5
2557
2.
CUP
/ /
/
CUP
3.
(step-bystep)
4.
5.
31
o
(),,,
4
25 )
:
(Milestone)
5
(Milestone)
32
1
2
3
4
5
1
1.
.. 2557
2.
CUP
3.
2
1. CUP
. 25
3
0.1
25 0.1
2.
2.1
33
2.2
2
1. ..
20
- 2
-
(SI-2) 10
- 3
-
2.
50
- 10
-
(SI-2) 15
- 5
-
34
3. 6 ,
9 12 20 .. 2557
, 20 .. 2557 15 .. 2557
0.1
80
15
2557 25
0.1
35
: 081-8873562
1. .
: 083-2178557
2. .
: 0
12
10
/
/
2557 2556
10
A 2556
B 2557
= (B-A) X 100/ A
36
//
:
1
2
3
4
5
10
(Baseline Data)
2555
+6
2556
- 7.52
-3.95
+ 0.30
37
13
10
/
/
2557 2556 10
A 2556
B
2557
= (B-A) X
100/ A
//
38
:
1
2
3
4
5
10
(Baseline Data)
255 255 255
4
5
6
n/a n/a n/a
n/a
n/a
n/a
14
20
39
/
/
2557
2556 20
A
2556
B
2557
= (BA) X 100/ A
//
1
2
3
4
5
8
11
14
17
20
40
(Baseline Data)
255 255 255
4
5
6
n/a n/a n/a
n/a
n/a
n/a
15 : 30,35,40,45,50,55
60
/ :
80
: 2
:
41
Pap Smear
VIA
30,35,40,45,50,55,60
(A)
30,35,40,45,50,55
60
. .2497,2502,2507,2512,2517,2522 . .2527)
Pap Smear VIA
(B)
30,35,40,45,50,55,60 ( ..2497,2502
,2507,2512,2517,2522 ..2527)
21
:
:
A X 100
B
42
1
40.0
2
50.0
3
60.0
4
70.0
5
80.0
//
:
1
1.
30,35,40,45,50,55 60
21
2.
Cxs2010
: 2556
30,35,40,45,50,55 60 35,545
Pap Smear 16,113
48.4 26.3
2555
74.7 23,612
Pap Smear
17,653 13.7 2554
/
:
1
:
1
43
(CUP)
:
1.
2. slide
slide
3.
Cxs2010
4.
:
1.
2.
slide
3.
Cxs2010
44
4.
:
8188 78806
:
8970 69870
16
: 0
: 0
(Conversion rate)
/ :
92
: 1
:
1
45
1. direct smear
1
2. direct smear 1
3. 1
:
x100
:
1
80.0
2
83.0
3
86.0
4
89.0
5
92.0
//
:
3
1. 3
0- 3 (TB 07)
2. 3
6 9
(TB 07/1) Cohort 3/2556 2/2557
:
46
255 255 25 25 25 25
1
2
53 54 55 56
83.9 86.2
88.
9
91.
1
91
.9
92.
2
/
:
1. /
/
2.
DOT / /
3.
47
:
:
1.
DOT
2.
:
: 0 8188 78806
:
.
: 0 8362 31991
48
17 : 10
( 10 )
(Response time)
/ :
85
: 1
:
(./.) 10 (Response
time) (A)
(..)
(.)
10 ( 10
)
10 (B)
49
(.)
10
(./.)
:
A X 100
B
:
1
65.0
2
70.0
3
75.0
4
80.0
5
85.0
//
:
:
2539
(FR)
10
255 2555 2556
4
70. 85.5 67.7
54
50
/
:
(..)
(.
)
10 ( 10
10 (
10 )
Response time
Dispatch time (Dispatch time
2 )
:
EMS
EMS EMS
:
1.
2.
51
EMS
EMS EMS
:
: 0 8188 78806
:
: 0 8188 78806
18 : 2nd Generation
/
/ : 15
: 1
:
52
Generation 2
/
(index case) 20
2 nd Generation 20 45
45 (Generation)
:
:
2nd Generation
/
= / 2nd
Generation x 100
:
1
35.0
30.0
25.0
20.0
15.0
//
:
506 / 507
:
53
31.
89
22.
12
30.
5
/
:
.
:
KPI
:
2 nd
54
50
:
: 0 8188 78806
:
: 0 8967 06117
55
19 :
(Pre diabetes)
/ : 7.0
: 2
:
(A)
35
(
FPG FCG
126 ./.)
(B)
35
2556
(Pre diabetes ,
FPG
FCG 100125 ./.)
:
A X 100
B
:
1
15.0
2
13.0
3
11.0
4
9.0
5
7.0
//
:
21
NCD2557
56
:
/
(Pre diabetes) 2556
10.
9
5.2
: 0 8188 78806
:
: 0 8916 26448
20 :
(Pre hypertension)
/ : 6.0
: 2
:
57
(A)
35
(
140 . /
90 .)
(B)
35 2556
(Pre hypertension ,
120 - 139 . /
80 - 89 .)
:
A X 100
B
//
:
NCD2557
21
:
1
10.0
2
9.0
3
8.0
4
7.0
5
6.0
:
/
58
(Pre
NA
7.5
4.2
hypertension) 2556
:
: 0 8188 78806
:
: 0 8916 26448
21 : 15
/ :
90.0
: 1
:
15
(A) 15
(Fasting plasma glucose Fasting capillary
glucose )
15-34
3 4
59
1. ( 90 .
80 . >25 /
.)
2.
3. ( BP 140/90 .)
4.
35-59
1 6
1. ( 90 .
80 . >25 /
.)
2.
3. ( BP 140/90 .)
4. (
250 ./. / <35 ./.)
5. (
2 (OGTT) = 140-199 ./
.
6.
60
15 (B)
15
( 6 )
:
A X 100
B
:
2557
1
50.0
2
60.0
3
70.0
4
80.0
5
90.0
0.3
//
:
NCD2557
21
:
/
15
61
: 0 8188 78806
:
: 0 8916 26448
22 : 15
/ :
90.0
: 1
62
:
15
(A) 15
30
5
2
BP
<120/80 mmHg 1 120/80 mmHg
15
15 (B)
15
( 6 )
:
A X 100
B
:
2557
1
50.0
2
60.0
3
70.0
4
80.0
5
90.0
0.3
//
:
63
NCD2557
21
:
/
15
: 0 8188 78806
:
: 0 8916 26448
23
()
2
1.
64
/
.. 2551
.. 2537 -
.. 2547
2.
13
/ /
1. /
2.
3.
1
4
2
3
3
2
4
1
65
CUP
:
: 056-232001 136
24
: 056-232001 136
(..)/
(.)
(.)
/ 60
1
66
(..) (.)
(..) (.)
(..)/
(.)
(..)/
(.)
60 : 40
../. .
67
(A x 100)
A+B
(B x 100)
A+B
../
.
B
20
%
30
%
40
%
50
%
60
%
60
/ /
:
21
60
52-56
255 255 255 2555 255
2
3
4
6
NA NA NA
NA
60.3
1
68
69
25
/
12
1
/
70
( + +
)
ANC EPI
/()X 100
( + + )
4 % = 1 , 6 % = 2 , 8
% = 3 , 10 % = 4 , 12 % = 5
(Baseline Data) 2556
12.87
/
4%
6%
8%
10 %
12 %
71
//
25
52
25 25 25
53 54 55
25
56
3.7
2
5.6
3
12.
87
Cup
6.2
1
8.9
6
72
26
(HA Accreditation)
/
(HA Accreditation)
73
(Overall Scoring)
3
(HA
Accreditation)
(Overall Scoring)
(Overall Scoring) 3
(Hospital Accreditation)
(HA)
60
(HA )
(HPH)
(TQA)
74
1 [ 1.1
(LED) 1.2 (STM) 1.3
/(PCF) 1.4
( MRK) 1.5 (HRF) 1.6
(PCM) ]
2 [ 2.1
(RSQ) 2.2
(PFG) 2.3
(ENV) 2.4 (IC)
(MRS)
2.5
2.6 (MMS)
2.7
(DIN) 2.8 (DHS) 2.9
(COM)]
3 [3.1
4 [4.1
(PCR) 4.2
(CFR) 4.3 (FNR) 4.4
(HRR) 4.5 (SPR)
4.6 (LDR) 4.7
(HPR)]
(Overall Scoring)
(Overall Requirement)
75
(HA)
(
HA Scoring 2011
89
445 ) (1 5 )
1
2 :
3 :
4 :
Evaluation&Improvement,Innovation,Integretion(E13),
5 :
76
(89
)
(89 )
1
/
2.4
2.7
3.0
3.3
2.1
HA
./
: 1. HA accreditation
Re-accreditation
Re-accreditation
2. .
( .
./ . QRT )
77
1.
Hospital Miniprofile
Overall Chapter Scoring ( HA Scoring 2011
89
445 )
5
Gap analysis PSG : SIMPLE 5
MRA
2. 1
(1.1-1.6) 5 ./
2
3.
1
(1.1-1.6) 1
//
78
()(.) 1
30 2556
()
(.)
(QRT)
2 2 2 2 2 2 2 2
5 5 5 5 5 5 5 5
4 4 4 5 5 5 5 5
7 8 9 0 1 2 3 4
2
5
5
5
2
5
5
6
79
1.
1
4
6
2
0
(HA)
-
- 1
- 2
- 3
-
(Accredit)
2.
(Overall
Scoring)
-
01.99
- 2.002.99
-
3.00-.3.99
-
4.00-.5.00
0
0
1
1
0
2
0
0
1
1
0
2
0
0
1
1
0
2
0
0
0
1
1
2
0
0
0
1
1
2
0
0
0
1
1
2
0
0
0
1
1
2
0
0
0
1
1
2
0
0
0
1
0
3
2
5
3
3
1
1
0
2
0
0
1
1
0
2
0
7
4
2
0
3
1
0
0
80
HA Scoring
81
82
83
84
27
/
90
/ (../.)
:
(
) (../
.)
1.
2.
1
3.
2 4.
3 5.
4 6. (Service behavior)
5 7.
/ (../.)
85
()
(Continuous Improvement)
100
70
75
80
85
90
/
1.
( .1)
.2)
86
2.
(../.)
( .1)
3./
(../.) 2
1 - 2557
5 2557
2 - 2557
5 2557
25
47
25 25 25 25 25 25 25 25
48 49 50 51 52 53 54 55
25
56
83.
43
90.
39
61.
04
84.
98
78.
93
87
1. ../.
( .1)
2.
( .1)
( .2)
( .1)
5
100 )
88
( )
(Necessary bio-data)
) 1. (
) 2.
..................................
) 1.
) 2.
(
) 3.
) 4.
. .
(
) 5.
) 7.
) 6.
) 8.
........................
) 1. -- (
) 2.
) 3.
) 4.
) 5.
) 6.
) 7.
()......................................................
) 1.
) 2.
89
) 3.
) 4.
()......................................................
1.
2.
3.
4.
5.
6.
7.
8.
(
4)
(3)
(2)
(1)
90
9.
10.
11.
12.
13.
14.
15.
16.
17 18
17.
91
18.
19.
20.
21.
22.
23.
24.
25.
.........................................................................................
....................................................................................
.........................................................................................
....................................................................................
92
( .2)
Admit 2
Admit 5
(
100 )
( )
(Necessary bio-data)
) 1. (
) 2.
..................................
) 1.
) 2.
(
) 3.
) 4.
. .
(
) 5.
) 7.
) 6.
) 8.
..........................................
) 1. -- (
) 2.
93
) 3.
) 4.
) 5.
) 6.
) 7.
()......................................................
) 1.
) 2.
(
) 3.
) 4.
()......................................................
1.
2.
3.
4.
5.
(4
)
(3)
(2
)
(1)
94
6.
7.
8.
9.
10.
11.
12.
13.
1
14.
15
16
15.
16.
95
17.
18.
19.
20.
21.
(
)
22.
23.
24.
25.
26.
27
27.
28.
96
29.
30.
31.
.........................................................................................
....................................................................................
.........................................................................................
....................................................................................
97
:1
=
X 100
98
:
( = 56 /)
:
1
2
76 %
79 %
82 %
70 %
73 %
//
:
1.
2. 2
1 2556
2557
2 2556
2557
99
/ 6
2
(Knowledge
Management : KM)
(KM)
1)(problem-solving)
(improvement)
2)
3)
(innovation)
100
(KM)
1) 2)
3) 4)
5) 6)
7)
(KM)
1)
(CUP) (Performance Agreement) :
Knowledge Vision (KV) 2
1
: .......................................
(KPI)
(Obj
ecti
101
ve)
: ..........................................................................
.........................................
:
......
: ..........................................................................
...............................
KM : .....(
)....................................................................
.......
:
(.............................................
)
(...................................
.............)
(CEO)
:
(.............................................
.....)
102
(CKO)
103
.................................................
:
..
(K) :
....................................................................
(KPI) : ..............(
: ................................
1
2
(..
...
(..
...
104
2)
(CUP)
3) KM (CKO)
(KF) (KP)
4)(Knowledge Sharing : KS)
5)/(Knowledge
Assets : KA)
6) 3 , 6 , 9
, 12
........ (........
............. .................)
...............................................................
................
: (KM)
105
........ (........
............. .................)
...............................................................
................
/
:
:
:
(KM)
HA&HPH , HCQA , PMQA PCA
106
1
/
()
2 3 4 5
: (CUP)/
(KM)
1. (KM)
2557
2. 1)
(CUP) 1
2
(KM Action Plan) 2)
KM 3) (Knowledge
Sharing : KS) /
4) / (Knowledge Assets : KA)
5) KM / Performance
Indicators & Target 3 , 6
, 9 , 12
107
1 / 30 2557
3. / (Knowledge
Assets : KA)
(CUP)
Website 30 2557
//
1 /
Internet
30 2557
255 25 25 25 25 25
1
52 53 54 55 56
108
( KM)
2
(
2
(
(CUP)
3
(
13
35
40 64
) )
4
(
3
(
26
27
)
2
(
109